Stocks & AI: what moved, and why

HALO Halozyme Therapeutics, Inc.

Nasdaq · Healthcare

Wed, Nov 4 0.7× volume +1.3%
Tue, Nov 3 0.6× volume -0.3%
Mon, Nov 2 1.4× volume -1.5%

News this week

  1. Halozyme expects $1.86B-$1.925B 2026 revenue while raising non-GAAP EPS to $8.75-$9.05
    HALO +1.3%2 sourcesSeeking Alpha ·